What is the expected growth forecast for the Minimally Invasive Heart Valve Surgery Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Minimally Invasive Heart Valve Surgery Devices market?

Increasing demand for minimally invasive procedures and technological advancements drive the market.

What are the major challenges facing the Minimally Invasive Heart Valve Surgery Devices market?

High costs and limited availability of skilled professionals are major challenges.

Which regions are the leaders in the Minimally Invasive Heart Valve Surgery Devices market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the Minimally Invasive Heart Valve Surgery Devices market?

Top companies include Medtronic, Edwards Lifesciences, and Abbott Laboratories.

What are the future opportunities in the Minimally Invasive Heart Valve Surgery Devices market?

Emerging markets and advancements in robotics and artificial intelligence offer future opportunities.

What is the current regulatory landscape for the Minimally Invasive Heart Valve Surgery Devices market?

Regulatory bodies such as FDA and CE mark ensure device safety and efficacy.

Global Minimally Invasive Heart Valve Surgery Devices Market Value Is Forecast To Reach By 2034 With CAGR

Minimally Invasive Heart Valve Surgery Devices by Application (Hospital, Specialized Hospital, Others), by Types (Valve Repair Device, Valve Replacement Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Minimally Invasive Heart Valve Surgery Devices Market Overview

The Minimally Invasive Heart Valve Surgery Devices market refers to the industry that provides innovative solutions for the treatment of heart valve diseases. As the Minimally Invasive Heart Valve Surgery Devices market size continues to expand, it is essential to analyze the growth outlook, market forecast, and industry expansion to understand the current landscape. The scope of this market includes various types of devices such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) devices. The current Minimally Invasive Heart Valve Surgery Devices market size is approximately $7.5 billion. The market is expected to experience a significant growth forecast, with a compound annual growth rate (CAGR) of around 12% during the forecast period from 2026 to 2033, driven by macro drivers such as the increasing prevalence of heart valve diseases and the growing demand for minimally invasive procedures.

Loading chart…

Key forces shaping the industry include technology shifts towards more advanced and minimally invasive procedures, regulations such as FDA approvals, and consumer behavior driven by the increasing awareness of the benefits of minimally invasive surgeries. The largest region in the Minimally Invasive Heart Valve Surgery Devices market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends and developments to remain competitive.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Abbott; Edwards Lifesciences; B. Braun; KLS Martin Group; NeoChord; Cardio Medical; Giester; Fehling Surgical Instruments; Cardiac Dimensions; KDI; Hanyu Medical Technology; KingstronBio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Minimally Invasive Heart Valve Surgery Devices market is poised for significant growth, driven by technological advancements and shifting patient preferences. The Minimally Invasive Heart Valve Surgery Devices market size is expected to expand substantially, with a growth forecast that underscores the industry's potential for innovation and investment.

Growth Drivers2 items

Advances in transcatheter technologies have improved procedure outcomes, reducing recovery time and enhancing patient experience, thereby driving the adoption of Minimally Invasive Heart Valve Surgery Devices.

Increasing prevalence of heart valve disorders, coupled with an aging population, is fueling demand for Minimally Invasive Heart Valve Surgery Devices, contributing to the market's growth forecast.

Restraints2 items

High device costs and limited reimbursement coverage in certain regions are hindering the widespread adoption of Minimally Invasive Heart Valve Surgery Devices, affecting the Minimally Invasive Heart Valve Surgery Devices market size.

The need for specialized training and infrastructure to support Minimally Invasive Heart Valve Surgery Devices procedures is a significant barrier to entry for many healthcare providers, impacting market growth.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific, offer significant opportunities for growth due to their large and growing populations, increasing healthcare expenditure, and rising demand for Minimally Invasive Heart Valve Surgery Devices.

The development of next-generation Minimally Invasive Heart Valve Surgery Devices with improved efficacy and safety profiles presents a substantial opportunity for market players to differentiate themselves and capture market share.

Challenges2 items

Stringent regulatory requirements and the need for extensive clinical trials to support device approvals pose significant challenges for manufacturers of Minimally Invasive Heart Valve Surgery Devices, influencing the Minimally Invasive Heart Valve Surgery Devices market size.

Managing the supply chain and maintaining consistent product quality while meeting growing demand and reducing costs is a key challenge for industry participants, affecting the overall growth forecast of the Minimally Invasive Heart Valve Surgery Devices market.

Market Segmentation

Loading chart…

The Minimally Invasive Heart Valve Surgery Devices market can be segmented based on Application, which refers to the specific use cases of these devices. This segmentation category contributes to the overall market size by highlighting the various areas where these devices are utilized, such as transcatheter aortic valve replacement (TAVR) and mitral valve repair. Understanding the application segment is crucial for market taxonomy, as it enables industry players to tailor their products and services to meet the unique needs of each application area, ultimately driving growth in the Minimally Invasive Heart Valve Surgery Devices segmentation market.

Another key segmentation category in the Minimally Invasive Heart Valve Surgery Devices market is Types, which encompasses various subtypes of devices, including [object Object] and [object Object]. This segmentation category is vital, as it allows for a deeper analysis of the market dynamics, enabling companies to develop targeted strategies for each device type. By examining the types of devices used in minimally invasive heart valve surgeries, industry stakeholders can identify areas of opportunity and challenge, ultimately informing their product development and marketing efforts to capitalize on the growing demand for Minimally Invasive Heart Valve Surgery Devices.

Minimally Invasive Heart Valve Surgery Devices Segmentation Breakdown7 items

Application

Hospital

Specialized Hospital

Others

Types

Valve Repair Device

Valve Replacement Device

Regional Insights

Loading chart…

The Minimally Invasive Heart Valve Surgery Devices market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of minimally invasive procedures, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and advanced infrastructure. In Europe, drivers include a high adoption rate, favorable policies, and significant investments in research and development. Asia Pacific's growth is driven by a large and growing demographics, increasing adoption of minimally invasive procedures, and improving infrastructure. Latin America's growth is driven by increasing investments in healthcare, while the Middle East & Africa region is driven by a growing ecosystem and increasing adoption of minimally invasive procedures.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience the fastest growth. The Minimally Invasive Heart Valve Surgery Devices market growth in Latin America and the Middle East & Africa will be driven by increasing investments and a growing ecosystem. Overall, the global market is expected to experience significant growth, driven by increasing adoption of minimally invasive procedures and advancing technology.

Competitive Landscape

The Minimally Invasive Heart Valve Surgery Devices market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The Minimally Invasive Heart Valve Surgery Devices competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting their strategies to address these challenges and maintain their competitive edge.

Medtronic: regional expansion

Abbott: innovation pipeline

Edwards Lifesciences: premium pricing

B. Braun: local manufacturing

KLS Martin Group: OEM tie-ups

NeoChord: vertical integration

Key Minimally Invasive Heart Valve Surgery Devices Companies13 items

Medtronic

Abbott

Edwards Lifesciences

B. Braun

KLS Martin Group

NeoChord

Cardio Medical

Giester

Fehling Surgical Instruments

Cardiac Dimensions

KDI

Hanyu Medical Technology

KingstronBio

Market Ecosystem

The Minimally Invasive Heart Valve Surgery Devices ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem is characterized by a sequence of value-creating activities, including design, manufacturing, distribution, and post-sales support. The ecosystem's boundaries span across various stages, from raw material sourcing to end-user adoption, with each stage influencing the overall efficiency and effectiveness of the value chain.

Raw material suppliers — providing critical components

OEMs / manufacturers — designing and producing devices

Technology providers — developing enabling technologies

System integrators / EPCs — integrating devices into systems

Distributors / channel partners — facilitating device distribution

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing safety and efficacy standards

In the Minimally Invasive Heart Valve Surgery Devices ecosystem, value flows through the various participants, with each stage creating and capturing value. However, control points, such as regulatory approvals and reimbursement policies, can influence adoption rates. Dependency risks, including input constraints and standards compliance, can also impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between participants. A thorough understanding of this ecosystem, including its value chain analysis, is essential for navigating the complex interactions and dependencies within the Minimally Invasive Heart Valve Surgery Devices ecosystem.

Recent Industry Insights

The Minimally Invasive Heart Valve Surgery Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Edwards Lifesciences, have focused on advancing transcatheter aortic valve replacement technologies. Additionally, there have been notable mergers and acquisitions, including the acquisition of Abbott's vascular Closure business by Terumo Corporation.

Furthermore, several product and technology launches have taken place, such as the introduction of next-generation transcatheter mitral valve replacement systems. Regulatory changes, including the FDA's updated guidelines for medical device approvals, have also impacted the industry. These developments, along with shifts in consumer and enterprise trends, have driven the growth of the Minimally Invasive Heart Valve Surgery Devices market, with companies like Boston Scientific and Johnson & Johnson investing heavily in funding rounds and expansions to stay competitive.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Minimally Invasive Heart Valve Surgery Devices market outlook is highly attractive due to the increasing prevalence of heart valve diseases and the growing demand for minimally invasive procedures. The competitive intensity in this market is moderate, with key players investing heavily in research and development to improve device efficacy and safety. The long-term outlook for this market is positive, driven by advancements in technology and the expanding patient population.

The innovation landscape is rapidly evolving, with a focus on developing more efficient and cost-effective devices. However, the demand-supply balance is a key risk factor, as the market is highly dependent on the availability of skilled professionals and specialized equipment. Other risk factors include regulatory challenges and reimbursement issues. Overall, the Minimally Invasive Heart Valve Surgery Devices market is expected to experience significant growth, driven by the increasing adoption of minimally invasive procedures and the development of new and innovative devices.

11 items

1. Executive Summary

2. Minimally Invasive Heart Valve Surgery Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Minimally Invasive Heart Valve Surgery Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Minimally Invasive Heart Valve Surgery Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Specialized Hospital

6.1.3. Others

6.2. Global Minimally Invasive Heart Valve Surgery Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Valve Repair Device

6.2.2. Valve Replacement Device

6.3. Global Minimally Invasive Heart Valve Surgery Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Minimally Invasive Heart Valve Surgery Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Minimally Invasive Heart Valve Surgery Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Minimally Invasive Heart Valve Surgery Devices Market Competition by Key Manufacturers

8.1. Global Minimally Invasive Heart Valve Surgery Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Minimally Invasive Heart Valve Surgery Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Edwards Lifesciences

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. KLS Martin Group

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. NeoChord

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cardio Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Giester

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Fehling Surgical Instruments

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cardiac Dimensions

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. KDI

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Hanyu Medical Technology

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. KingstronBio

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Minimally Invasive Heart Valve Surgery Devices Market

Figure 4: Global Minimally Invasive Heart Valve Surgery Devices Market: Drivers

Figure 5: Global Minimally Invasive Heart Valve Surgery Devices Market: Challenges

Figure 6: Global Minimally Invasive Heart Valve Surgery Devices Market: Trends

Figure 7: Global Minimally Invasive Heart Valve Surgery Devices Market: Opportunity

Figure 8: Global Minimally Invasive Heart Valve Surgery Devices Market: Restraint

Figure 9: Global Minimally Invasive Heart Valve Surgery Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Minimally Invasive Heart Valve Surgery Devices Market Value (USD Million) By Region

Figure 15: Global Minimally Invasive Heart Valve Surgery Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Minimally Invasive Heart Valve Surgery Devices Market Value (USD Million) By Region

Figure 23: Global Minimally Invasive Heart Valve Surgery Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Minimally Invasive Heart Valve Surgery Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Minimally Invasive Heart Valve Surgery Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Minimally Invasive Heart Valve Surgery Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Minimally Invasive Heart Valve Surgery Devices Market Value (USD Million) By Region

Table 10: Global Minimally Invasive Heart Valve Surgery Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Minimally Invasive Heart Valve Surgery Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Minimally Invasive Heart Valve Surgery Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Minimally Invasive Heart Valve Surgery Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: Abbott Basic Information And Sales Area

Table 33: Abbott. Products Portfolio

Table 34: Edwards Lifesciences Basic Information And Sales Area

Table 35: Edwards Lifesciences. Products Portfolio

Table 36: B. Braun Basic Information And Sales Area

Table 37: B. Braun. Products Portfolio

Table 38: KLS Martin Group Basic Information And Sales Area

Table 39: KLS Martin Group. Products Portfolio

Table 40: NeoChord Basic Information And Sales Area

Table 41: NeoChord. Products Portfolio

Table 42: Cardio Medical Basic Information And Sales Area

Table 43: Cardio Medical. Products Portfolio

Table 44: Giester Basic Information And Sales Area

Table 45: Giester. Products Portfolio

Table 46: Fehling Surgical Instruments Basic Information And Sales Area

Table 47: Fehling Surgical Instruments. Products Portfolio

Table 48: Cardiac Dimensions Basic Information And Sales Area

Table 49: Cardiac Dimensions. Products Portfolio

Table 50: KDI Basic Information And Sales Area

Table 51: KDI. Products Portfolio

Table 52: Hanyu Medical Technology Basic Information And Sales Area

Table 53: Hanyu Medical Technology. Products Portfolio

Table 54: KingstronBio Basic Information And Sales Area

Table 55: KingstronBio. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Minimally Invasive Heart Valve Surgery Devices Market Value (USD Million) By Region

Table 61: Global Minimally Invasive Heart Valve Surgery Devices Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Minimally Invasive Heart Valve Surgery Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Abbott; Edwards Lifesciences; B. Braun; KLS Martin Group; NeoChord; Cardio Medical; Giester; Fehling Surgical Instruments; Cardiac Dimensions; KDI; Hanyu Medical Technology; KingstronBio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Minimally Invasive Heart Valve Surgery Devices Segmentation Breakdown7 items

Application

Hospital

Specialized Hospital

Others

Types

Valve Repair Device

Valve Replacement Device

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: regional expansion

Abbott: innovation pipeline

Edwards Lifesciences: premium pricing

B. Braun: local manufacturing

KLS Martin Group: OEM tie-ups

NeoChord: vertical integration

Key Minimally Invasive Heart Valve Surgery Devices Companies13 items

Medtronic

Abbott

Edwards Lifesciences

B. Braun

KLS Martin Group

NeoChord

Cardio Medical

Giester

Fehling Surgical Instruments

Cardiac Dimensions

KDI

Hanyu Medical Technology

KingstronBio

Market Ecosystem

Raw material suppliers — providing critical components

OEMs / manufacturers — designing and producing devices

Technology providers — developing enabling technologies

System integrators / EPCs — integrating devices into systems

Distributors / channel partners — facilitating device distribution

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents